Image

Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations

Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Compared to the general population, individuals from underserved communities are more likely to receive low quality end-of-life care and unwanted, costly and burdensome treatments due in part to a lack of advance care planning (ACP; the process of discussing wishes for end-of-life care with loved ones/clinicians and documenting them in advance directives).

This study will use existing, trusted, and respected social networks to evaluate two conversation-based tools intended to engage underserved individuals in discussions about end-of-life issue and motivate them to carry out ACP behaviors.

Through this study, investigators will learn how best to engage underserved populations in ACP so as to: 1) increase the likelihood that patients from underserved communities will receive high-quality end-of-life care; 2) address health disparities related to end-of-life treatments; and 3) reduce unnecessary suffering for patients and their families.

Description

The overall project goal of this 3-armed cluster, randomized control trial in underserved, diverse communities is to determine whether playing a serious conversation game called Hello is more effective than other advance care planning (ACP) approaches, or usual care (i.e., simply distributing an advance directive [AD]). The investigators will randomize 75 underserved communities across the US. The primary outcome is completion of a visually verified AD; secondary outcomes include performance of other ACP behaviors.

Many Black/African Americans and Latina/Latino patients are more likely to receive low quality end-of- life medical care than White individuals- in fact, they are 3 times more likely than white Americans to die after a lengthy intensive care unit stay. Advance care planning (ACP)- the process of discussing one's wishes with loved ones and clinicians, and then documenting them in an advance directive (AD)- can help reduce these health inequities by preventing costly/burdensome treatments that are unlikely to reduce suffering or improve quality of life. Though ~60% of Americans engage in ACP, <25% of underserved populations have done so- in large part due to distrust of the healthcare system/clinicians, and reluctance to discuss death and dying.

This study leverages underserved communities' existing, trusted social networks to deploy two community-based ACP interventions and study their mechanisms of action. By identifying which interventions increase engagement in ACP in underserved communities (and why), this project will help improve quality of end-of-life care, reduce unnecessary suffering, and end-of-life healthcare costs which conserves public health resources.

Eligibility

Inclusion Criteria Community Hosts

  1. Ability to recruit 20 individuals from underserved populations to attend a community event
  2. Experience hosting a community event
  3. Experience working with underserved populations
  4. Participation in a series of mandatory live study-related web-based trainings
  5. Completes a research site agreement

Research Participants

  1. Adults over the age of 18 years old in underserved populations
  2. Able to speak and read English and/or Spanish
  3. Have not completed an AD within the previous 5 years
  4. All participants regardless of health status
  5. Individuals from the same household can enroll

Exclusion Criteria Community Hosts

  1. Inability to recruit 20 individuals from underserved populations
  2. Inexperience for hosting a community event
  3. Inexperience working with underserved populations
  4. Unable to attend a series of mandatory live study-related web-based trainings
  5. Do not provide informed consent
  6. Do not complete a research site agreement
  7. Previously hosted a Hello project event

Research Participants

  1. Anyone <18 years of age
  2. Anyone not able to speak and read English and/or Spanish
  3. Have significant difficulties with hearing or speaking difficulties by self-report
  4. Completed an AD in the past 5 years
  5. Do not provide informed consent

Study details
    Advance Care Planning
    Advance Directives
    Terminal Illness
    Chronic Illness
    Communication

NCT04612738

Milton S. Hershey Medical Center

29 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.